Publications

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines for Europe Country Specific Market Access Policies

23 May 2017

Policy

Open

Positioning Statements on Physician-led Switching for Biosimilar Medicines

7 March 2017

Policy

Positioning Statements on Physician-led Switching for Biosimilar Medicines BIOSIMILAR MEDICINES […]

Read more

Essential Medicines for Universal Health Coverage

7 November 2016

Policy

Open

Medicines for Europe’s Contribution to WHO’s Biological Qualifier (BQ) Developments (PRESENTATION and SPEECH)

18 October 2016

Policy

      18 October 2016 Suzette Kox Senior Director […]

Read more

Understanding the Science of Extrapolation and Defining Interchangeability – Dr. Elena Wolff-Holz, EULAR Symposium London

10 June 2016

Policy

Open

EGA-EBG Summary Position Regarding the WHO Biologic Qualifier Proposal (INN Working Doc. 14.342)

21 March 2016

Policy

Open

Biosimilar Product Labelling

2 February 2016

Policy

Open

The value of generic medicines

26 November 2015

Policy

Read more about the value of generic medicines PDF version or […]

Read more

EGA-EBG Considerations on WHO’s BQ Proposal – Suzette Kox, WHO INN Open Session with Stakeholders, Geneva, 13 October 2015 (PPT)

13 October 2015

Policy

Open

Investing in People Centred Health Service Delivery – Paul Cornes, Riga Health Conference – How to Improve Health Systems Through Technology? 29-30 June 2015, Riga, Latvia (PPT)

29 June 2015

Policy

Open

Subscribe to our newsletter